• Contagion LiveContagion Live
  • CGTLive logoCGTLive logo
  • HCP Live
  • Neurology LiveNeurology Live
  • OncLiveOncLive
HCPLive - Clinical news for connected physicians
HCPLive - Clinical news for connected physicians
Spotlight
COVID-19Sickle Cell Disease
Clinical
View MoreADHDAllergyArterial DiseaseCardiologyDermatologyDiabetesGastroenterologyGeriatric MedicineInfectious DiseaseInflammationNeurologyPsychiatryPulmonologyRheumatology
Video Series
InsightsNews NetworkPeers & PerspectivesPost Conference Perspectives
News
Media
Medical World News
Peer Exchange
Podcasts
Videos
Webinars
Conferences
Conference Coverage
Conference Listing
PartnersCME/CE
Resources
Exclusive Content
Interactive Tools
Live Events
Press Release
Publications
Sponsored
Subscribe
  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions

© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.

Spotlight
  • COVID-19
  • Sickle Cell Disease
ClinicalSee All >
  • ADHD
  • Allergy
  • Arterial Disease
  • Cardiology
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Geriatric Medicine
  • Infectious Disease
  • Inflammation
  • Neurology
  • Psychiatry
  • Pulmonology
  • Rheumatology
Video Series
  • Insights
  • News Network
  • Peers & Perspectives
  • Post Conference Perspectives
hcplive podcasts
  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.

Advances in Treatment of Obstructive Hypertrophic Cardiomyopathy

Experts in cardiovascular medicine share strategies for the practical management of obstructive hypertrophic cardiomyopathy.

EP. 1: Overview of Hypertrophic Cardiomyopathy

May 6th 2022

Martin S. Maron, MD, discusses the incidence and prevalence of hypertrophic cardiomyopathy and age of disease expression.

EP. 2: Role of Genetic Mutations in HCM Pathophysiology

May 6th 2022

Steve R. Ommen, MD, leads a review of common mutations seen in hypertrophic cardiomyopathy and the role of biomarkers and genetic testing in HCM.

Latest News

Organizations Call on FDA To Help Address Recurrent C Difficile Burdens

Wonder Drake, MD: Understanding the Progression Patterns of Sarcoidosis

Presence of Residual Subretinal Fluid May Be Linked to Better BCVA in nAMD Treatment

View More News